You are here: 

Stories

Dr Robert Day Targeting an “evil twin” enzyme in prostate cancer

Funding world-class research

Icon - paper

Cancer affects all Canadians but together we can reduce the burden by investing in research and prevention efforts. Learn about the impact of our funded research.

Learn more